Current  ||| S:0 E:8 ||| JJ
situation  ||| S:8 E:18 ||| NN
and  ||| S:18 E:22 ||| CC
ethical-social  ||| S:22 E:37 ||| JJ
issues  ||| S:37 E:44 ||| NNS
of  ||| S:44 E:47 ||| IN
pediatric  ||| S:47 E:57 ||| JJ
genetic  ||| S:57 E:65 ||| JJ
testing  ||| S:65 E:73 ||| NN
Many  ||| S:73 E:78 ||| JJ
pediatric  ||| S:78 E:88 ||| JJ
neurological  ||| S:88 E:101 ||| JJ
disorders  ||| S:101 E:111 ||| NNS
are  ||| S:111 E:115 ||| VBP
caused  ||| S:115 E:122 ||| VBN
by  ||| S:122 E:125 ||| IN
genetic  ||| S:125 E:133 ||| JJ
factors ||| S:133 E:140 ||| NNS
.  ||| S:140 E:142 ||| .
Therefore ||| S:142 E:151 ||| RB
,  ||| S:151 E:153 ||| ,
genetic  ||| S:153 E:161 ||| JJ
testing  ||| S:161 E:169 ||| NN
is  ||| S:169 E:172 ||| VBZ
often  ||| S:172 E:178 ||| RB
required  ||| S:178 E:187 ||| VBN
for  ||| S:187 E:191 ||| IN
final  ||| S:191 E:197 ||| JJ
diagnosis ||| S:197 E:206 ||| NN
,  ||| S:206 E:208 ||| ,
prognosis  ||| S:208 E:218 ||| JJ
prediction ||| S:218 E:228 ||| NN
,  ||| S:228 E:230 ||| ,
and  ||| S:230 E:234 ||| CC
genetic  ||| S:234 E:242 ||| JJ
counseling ||| S:242 E:252 ||| NN
.  ||| S:252 E:254 ||| .
Prior  ||| S:254 E:260 ||| RB
to  ||| S:260 E:263 ||| TO
performing  ||| S:263 E:274 ||| VBG
genetic  ||| S:274 E:282 ||| JJ
research ||| S:282 E:290 ||| NN
,  ||| S:290 E:292 ||| ,
pediatric  ||| S:292 E:302 ||| JJ
neurologists  ||| S:302 E:315 ||| NNS
must  ||| S:315 E:320 ||| MD
obtain  ||| S:320 E:327 ||| VB
the  ||| S:327 E:331 ||| DT
approval  ||| S:331 E:340 ||| NN
of  ||| S:340 E:343 ||| IN
the  ||| S:343 E:347 ||| DT
Institutional  ||| S:347 E:361 ||| NNP
Review  ||| S:361 E:368 ||| NNP
Board ||| S:368 E:373 ||| NNP
.  ||| S:373 E:375 ||| .
Moreover ||| S:375 E:383 ||| RB
,  ||| S:383 E:385 ||| ,
according  ||| S:385 E:395 ||| VBG
to  ||| S:395 E:398 ||| TO
the  ||| S:398 E:402 ||| DT
Ethical  ||| S:402 E:410 ||| JJ
Guidelines  ||| S:410 E:421 ||| NNS
for  ||| S:421 E:425 ||| IN
Human  ||| S:425 E:431 ||| NNP
Genome ||| S:431 E:437 ||| NNP
/ ||| S:437 E:438 ||| NNP
Gene  ||| S:438 E:443 ||| NNP
Analysis  ||| S:443 E:452 ||| NNP
Research ||| S:452 E:460 ||| NNP
,  ||| S:460 E:462 ||| ,
anonymity  ||| S:462 E:472 ||| NN
of  ||| S:472 E:475 ||| IN
patient  ||| S:475 E:483 ||| JJ
samples  ||| S:483 E:491 ||| NNS
must  ||| S:491 E:496 ||| MD
be  ||| S:496 E:499 ||| VB
maintained ||| S:499 E:509 ||| VBN
.  ||| S:509 E:511 ||| .
Although  ||| S:511 E:520 ||| IN
the  ||| S:520 E:524 ||| DT
guideline  ||| S:524 E:534 ||| NN
for  ||| S:534 E:538 ||| IN
genetic  ||| S:538 E:546 ||| JJ
research  ||| S:546 E:555 ||| NN
are  ||| S:555 E:559 ||| VBP
not  ||| S:559 E:563 ||| RB
generally  ||| S:563 E:573 ||| RB
applied  ||| S:573 E:581 ||| VBN
for  ||| S:581 E:585 ||| IN
genetic  ||| S:585 E:593 ||| JJ
testing  ||| S:593 E:601 ||| NN
in  ||| S:601 E:604 ||| IN
routine  ||| S:604 E:612 ||| JJ
bedside  ||| S:612 E:620 ||| JJ
medical  ||| S:620 E:628 ||| JJ
care ||| S:628 E:632 ||| NN
,  ||| S:632 E:634 ||| ,
the  ||| S:634 E:638 ||| DT
guideline  ||| S:638 E:648 ||| NN
adopted  ||| S:648 E:656 ||| VBN
by  ||| S:656 E:659 ||| IN
the  ||| S:659 E:663 ||| DT
Japan  ||| S:663 E:669 ||| NNP
Medical  ||| S:669 E:677 ||| NNP
Association  ||| S:677 E:689 ||| NNP
must  ||| S:689 E:694 ||| MD
be  ||| S:694 E:697 ||| VB
followed ||| S:697 E:705 ||| VBN
,  ||| S:705 E:707 ||| ,
because  ||| S:707 E:715 ||| IN
genetic  ||| S:715 E:723 ||| JJ
information  ||| S:723 E:735 ||| NN
from  ||| S:735 E:740 ||| IN
a  ||| S:740 E:742 ||| DT
personal  ||| S:742 E:751 ||| JJ
genome  ||| S:751 E:758 ||| NN
is  ||| S:758 E:761 ||| VBZ
patient-specific ||| S:761 E:777 ||| JJ
.  ||| S:777 E:779 ||| .
Pediatric  ||| S:779 E:789 ||| JJ
neurologists  ||| S:789 E:802 ||| NNS
must  ||| S:802 E:807 ||| MD
also  ||| S:807 E:812 ||| RB
be  ||| S:812 E:815 ||| VB
aware  ||| S:815 E:821 ||| JJ
of  ||| S:821 E:824 ||| IN
the  ||| S:824 E:828 ||| DT
policies  ||| S:828 E:837 ||| NNS
adopted  ||| S:837 E:845 ||| VBD
to  ||| S:845 E:848 ||| TO
obtain  ||| S:848 E:855 ||| VB
informed  ||| S:855 E:864 ||| VBN
consent  ||| S:864 E:872 ||| NN
from  ||| S:872 E:877 ||| IN
children  ||| S:877 E:886 ||| NNS
and  ||| S:886 E:890 ||| CC
patients  ||| S:890 E:899 ||| NNS
who  ||| S:899 E:903 ||| WP
are  ||| S:903 E:907 ||| VBP
incapable  ||| S:907 E:917 ||| VBN
of  ||| S:917 E:920 ||| IN
making  ||| S:920 E:927 ||| VBG
their  ||| S:927 E:933 ||| PRP$
own  ||| S:933 E:937 ||| JJ
decisions ||| S:937 E:946 ||| NNS
.  ||| S:946 E:948 ||| .
They  ||| S:948 E:953 ||| PRP
should  ||| S:953 E:960 ||| MD
develop  ||| S:960 E:968 ||| VB
a  ||| S:968 E:970 ||| DT
strategy  ||| S:970 E:979 ||| NN
for  ||| S:979 E:983 ||| IN
collaboration  ||| S:983 E:997 ||| NN
with  ||| S:997 E:1002 ||| IN
clinical  ||| S:1002 E:1011 ||| JJ
geneticists  ||| S:1011 E:1023 ||| NN
and  ||| S:1023 E:1027 ||| CC
for  ||| S:1027 E:1031 ||| IN
making  ||| S:1031 E:1038 ||| VBG
a  ||| S:1038 E:1040 ||| DT
prenatal  ||| S:1040 E:1049 ||| JJ
diagnosis ||| S:1049 E:1058 ||| NN
.  ||| S:1058 E:1060 ||| .
